Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agenus Inc AGEN

Healthcare Biotechnology
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its... see more

Recent & Breaking News (NDAQ:AGEN)

November 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AGEN

Accesswire November 3, 2024

The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Agenus Inc.

Accesswire November 3, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 5, 2024 in Agenus Lawsuit - AGEN

Accesswire November 3, 2024

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

PR Newswire November 3, 2024

Agenus Inc. Class Action: Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024 - AGEN

Accesswire November 3, 2024

AGEN Stockholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!

Accesswire November 3, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders

Accesswire November 2, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming Deadlines - AGEN

PR Newswire November 2, 2024

Agenus Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Accesswire November 2, 2024

Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AGEN

Accesswire November 1, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Newsfile November 1, 2024

AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire November 1, 2024

AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire November 1, 2024

Investors in Agenus Inc. Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

PR Newswire November 1, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders

Accesswire October 31, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Newsfile October 31, 2024

Agenus Inc. Class Action: Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024 - AGEN

Accesswire October 31, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Agenus Inc. (AGEN) Shareholders

Accesswire October 31, 2024

Agenus Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AGEN

Accesswire October 31, 2024

The Schall Law Firm Encourages Investors To Take Part In A Securities Fraud Case Against Agenus Inc.

Accesswire October 31, 2024